Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT Colonography Beats Stool DNA Testing for Colon Cancer Screening

By MedImaging International staff writers
Posted on 10 Jun 2025

As colorectal cancer remains the second leading cause of cancer-related deaths worldwide, early detection through screening is vital to reduce advanced-stage treatments and associated costs. More...

In response to a growing incidence in younger populations, the U.S. Preventive Services Task Force has revised the recommended starting age for colorectal screening to 45. While colonoscopy is still the gold standard due to its ability to remove precancerous polyps, expanded Medicare coverage now includes less invasive methods such as multitarget stool DNA (mt-sDNA) testing and CT colonography. Now, a new study has found CT colonography to be both clinically effective and cost-saving when compared to stool DNA testing.

In the study, researchers at the University of Wisconsin School of Medicine and Public Health (Madison, WI, USA) compared mt-sDNA and CT colonography head-to-head. Using a Markov model, they simulated colorectal disease progression in a population of 10,000 individuals starting at age 45 and continuing until age 75, assuming perfect adherence to all screenings and follow-ups. Health states were assigned annually based on lesion presence and size. Without screening, 7.5% of the simulated population developed colorectal cancer.

Published in Radiology, the findings show that both methods were clinically beneficial compared to no screening. However, CT colonography led to a greater reduction in cancer incidence, between 70% to 75%, versus 59% for mt-sDNA. To evaluate cost-effectiveness, the team used Quality-Adjusted Life Years (QALYs), where one QALY equals one year in perfect health. mt-sDNA offered good value at a cost of around USD 9,000 per QALY gained, below the USD 100,000 threshold. In contrast, CT colonography was found to be outright cost-saving compared to no screening.

Because large polyps (≥10 mm) are the key target for prevention, the study also tested a hybrid strategy: 3-year surveillance of small polyps (6–9 mm) using CT colonography, with colonoscopy referrals only for large polyps. When compared to the conventional approach—referring all polyps ≥6 mm for colonoscopy—the hybrid strategy was more cost-effective. The conventional method led to higher colonoscopy-related costs that were not justified by the minimal additional QALYs gained. The findings suggest that a hybrid screening approach combining CT colonography surveillance for small polyps with targeted colonoscopy referrals provides the best balance between cost and clinical benefit.

“Among the safe, minimally invasive colorectal cancer screening options, CT colonography is more effective at preventing and detecting cancer—and is also more cost-effective—than stool DNA testing,” said study author Perry J. Pickhardt, M.D. “Furthermore, CT colonography can provide for extracolonic screening for things like osteoporosis and cardiovascular disease.”

Related Links:
UW School of Medicine and Public Health


Breast Localization System
MAMMOREP LOOP
New
MRI System
nanoScan MRI 3T/7T
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Biopsy Software
Affirm® Contrast
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.